InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-16.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Yarema Kristin, Directeur Commercial. Insider active across 3 companies, notably Atara Biotherapeutics, Inc.. In total, 8 disclosures have been logged. Breakdown: 2 buys · 2 sells. Total volume traded: €66k. Activity tracked since 18 May 2021. The latest transaction was filed on 2 January 2024 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations8 total
615,836 sharesCommon StockSEC:0001415889-25-001080:0
250,000 shares0Common StockSEC:0000950170-24-001835:0
356,836 shares0Common StockSEC:0001209191-23-024103:0
45,533 shares0Common StockSEC:0001140361-22-007766:0
2,021 shares@ US$14.500.030% mcap57.1% of flowCommon StockSEC:0001567619-21-012110:0
Ideal exit: 8 Mar 2022 (T+270)
2,021 shares@ US$14.50100.0% of flowCommon StockSEC:0001567619-21-012110
Ideal exit: 8 Mar 2022 (T+270)
761 shares@ US$14.5521.5% of flowCommon StockSEC:0001209191-21-034422
761 shares@ US$14.550.011% mcap21.5% of flowCommon StockSEC:0001209191-21-034422:0
8 of 8 declarations
About Yarema Kristin
Kristin Yarema is the Chief Commercial Officer at Atara Biotherapeutics, Inc. She is responsible for the commercial strategy and direction of the company's activities. Her role is crucial in developing initiatives aimed at increasing market share and strengthening the company's position in the biopharmaceutical sector. She brings her expertise in management and commercial strategy.
